Influence on platelet aggregation of i.v. parecoxib and acetaminophen in healthy volunteers
Open Access
- 12 May 2006
- journal article
- research article
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 97 (2) , 226-231
Abstract
Background. Acetaminophen (paracetamol) alone or in combination with other analgesics is widely used for postoperative analgesia. While acetaminophen and non-steroidal anti-inflammatory drugs inhibit platelet function, the cyclooxygenase-2 (COX-2) selectively inhibiting coxibs show no interference with platelet function. The authors studied the effect of a combination of i.v. parecoxib and acetaminophen on platelet function in healthy volunteers. Methods. Eighteen healthy, male volunteers (22–33 yr) received i.v. acetaminophen 1 g, parecoxib 40 mg+acetaminophen 1 g or placebo in a double-blind, crossover study. Platelet function was assessed by photometric aggregometry and by measuring the release of thromboxane B2. Plasma acetaminophen concentrations were measured by high-performance liquid chromatography. Results. Platelet aggregation (median area under the curve) triggered with arachidonic acid 500 µM was 24.6, 3.9 and 4.2×103 area units (P=0.02, all groups) after placebo, acetaminophen and parecoxib+acetaminophen, respectively. Inhibition of platelet aggregation showed no difference between acetaminophen alone and the combination (P=0.82). Aggregation triggered with arachidonic acid 750 or 1000 µM, adenosine diphosphate (ADP) 1.5 or 3 µM, or epinephrine 5 µM showed no differences between the groups. Release of thromboxane B2 in response to ADP was inhibited similarly by both acetaminophen and the combination. Plasma acetaminophen concentrations were similar after acetaminophen and the combination. Conclusions. Acetaminophen and parecoxib showed no interaction in inhibiting platelet function. In combination they cause a mild degree of COX-1 inhibition corresponding to that of acetaminophen alone.Keywords
This publication has 28 references indexed in Scilit:
- Characterization of inhibition of platelet function by paracetamol and its interaction with diclofenac in vitroActa Anaesthesiologica Scandinavica, 2005
- Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention TrialNew England Journal of Medicine, 2005
- Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma PreventionNew England Journal of Medicine, 2005
- Complications of the COX-2 Inhibitors Parecoxib and Valdecoxib after Cardiac SurgeryNew England Journal of Medicine, 2005
- Platelet Receptors for Adenine Nucleotides and Thromboxane A2Seminars in Thrombosis and Hemostasis, 2004
- Parecoxib (Parecoxib Sodium)Drugs, 2001
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- Platelet prostanoid receptorsPharmacology & Therapeutics, 1996
- Nonlinear regression using spreadsheetsTrends in Pharmacological Sciences, 1995
- Inhibition of Prostaglandin Synthetase in Brain explains the Anti-pyretic Activity of Paracetamol (4-Acetamidophenol)Nature, 1972